The Centre has positioned an order to procure 66 crore more doses of Covishield and Covaxin to be provided between August and December this yr, at a revised worth of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources knowledgeable PTI.
Sources stated 37.5 crore of Covishield doses from the Serum Institute of India and 28.5 crore Covaxin doses from (*66*) Biotech will likely be procured by December.
“An order to procure 66 crore more doses of COVID-19 vaccines–Covishield and Covaxin–to be supplied between August and December, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, has been placed,” the supply stated.
The worth of every dose of Covishield quantities to Rs 215.25 and Covaxin Rs 225.75, together with taxes, it stated.
The Union well being ministry which was procuring each the vaccines at Rs 150 per dose, had indicated that the costs can be revised after the brand new COVID-19 vaccine procurement coverage got here into impact from June 21. Under the brand new coverage, the ministry will procure 75 per cent of the vaccines being produced by the drug producers within the nation.
While the Centre has requested each the vaccine manufacturing corporations to scale up their manufacturing, the producers had indicated that getting Rs 150 for every dose whereas making investments to ramp up the manufacturing was not viable for them, sources stated.
The Union authorities had earlier allowed states and personal hospitals to procure 50 per cent of the vaccines following calls for for decentralisation of the method.
However, after a number of states complained of issues together with of funding, Prime Minister Narendra Modi introduced the revision of the vaccine tips on June 8.
Domestic vaccine producers are given the choice to present 25 per cent of their month-to-month manufacturing of vaccines to non-public hospitals.
According to the revised tips which got here into impact from June 21, vaccine doses offered free of price by the Centre will likely be allotted to states/UTs based mostly on standards equivalent to inhabitants, illness burden and the progress of vaccination, and all above the age of 18 will likely be eligible for the free jabs.
Any wastage of vaccine will have an effect on the allocation negatively.
The states and UTs would mixture the demand of non-public hospitals protecting in view equitable distribution between massive and small non-public hospitals and regional stability.
“Based on this aggregated demand, the Government of India will facilitate the supply of these vaccines to the private hospitals and their payment through the National Health Authority’s electronic platform. This would enable the smaller and remoter private hospitals to obtain a timely supply of vaccines, and further equitable access and regional balance,” the ministry had stated.
The worth of vaccine doses for personal hospitals can be declared by every vaccine producer, and any subsequent modifications can be notified upfront, it stated.
More than 41.69 crore vaccine doses have been offered to states and UTs thus far, by way of all sources, the well being ministry stated on Saturday.
(With PTI inputs)